ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

ClinicalTrials.gov ID: NCT00832507

Public ClinicalTrials.gov record NCT00832507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects With Pulmonary Arterial Hypertension

Study identification

NCT ID
NCT00832507
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
162 participants

Conditions and interventions

Interventions

  • Cicletanine Drug
  • Cicletanine Placebo Drug

Drug

Eligibility (public fields only)

Age range
16 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Sep 30, 2011
Completion
Feb 29, 2012
Last update posted
Feb 3, 2014

2009 – 2012

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
University of South Alabama Mobile Alabama 36617
Arizona Pulmonary Specialists Phoenix Arizona 85013
VA Greater LA Healthcare System Los Angeles California 90073
University of California San Diego Medical Center San Diego California 92037
Harish H. K. Murthy, MD San Jose California 95124
UCLA Medical Center Torrance California 90502
University of Colorado Denver Aurora Colorado 80045
University of Connecticut Health Center Farmington Connecticut 06030
Cleveland Clinic Fort Lauderdale Florida 33331
University of Florida Gainesville Florida 32610
Emory University Atlanta Georgia 30322
Medical College of Georgia Augusta Georgia 30912
University of Chicago Hospital Chicago Illinois 60637
University of Iowa Iowa City Iowa 52242
Louisiana State University New Orleans Louisiana 70112
University of Maryland Baltimore Maryland 21201
Tufts-New England Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Children's Hospital Boston Boston Massachusetts 02115
Boston University School of Medicine Boston Massachusetts 02118
Mayo Clinic Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Beth Israel Medical Center New York New York 10003
Cornell University New York New York 10021
Mount Sinai Medical Center New York New York 10029
New York Presbyterian Hospital New York New York 10032
University of Rochester Rochester New York 14623
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
The Lindner Clinical Trial Center Cincinnati Ohio 45219
Case Medical Center Cleveland Ohio 44106
Davis Heart and Lung Research Institute Columbus Ohio 43210-1252
University of Pennsylvania Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Rhode Island Hospital Providence Rhode Island 02903
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390
Baylor College of Medicine Houston Texas 77030
Intermountain Medical Center Murray Utah 84157
University Of Virginia Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00832507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2014 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00832507 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →